LD-2 disclosure · 3rd Quarter - Report
ALLIANCE FOR AGING RESEARCH
Coverage · No income or expenses were reported on this filing.
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Non-profit healthcare advocacy organization
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
-H.R. 485 Protecting Health Care for All Patients Act of 2023 -FDA on status of safe and effective decongestants -HHS on health disparity populations -Food and Drug Administration's Patient-Focused Drug Development Series
LobbyistsMICHAEL WARD · ms ADINA ROSE LASSER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Medicare/Medicaid
-Implementation of Medicare Part D beneficiary affordability provisions -Use of Explanation of Benefits to educate and inform beneficiaries -Proposed National Coverage Determination (NCD) for Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Infection Prevention -Proposed NCD for Aꞵ Positron Emission Tomography scans -Proposed guidance on National Coverage Analysis process -Proposed guidance on Coverage with Evidence Development -Proposed guidance on Transitional Coverage for Emerging Technologies pathway -CY 2024 OPPS/PFS Final Rule -Stakeholder input in the Medicare drug price negotiation process -AP quality measure on antipsychotics for long-term stay in secure nursing facilities
LobbyistsMICHAEL WARD · ms ADINA ROSE LASSER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriations